Benign liver tumors are often harmless and can be treated conservatively. In some cases, though, treatment is indicated to prevent secondary complications such as bleeding or transformation into hepatocellular carcinoma. In order to prevent both over and under treatment clear and concise guidelines are needed. The current thesis explores the current European treatment guideline on benign liver tumors and examines the areas on which data are lacking and/or guideline recommendations can be evolved.